33 YEARS OF EXCELLENCE IN OCULAR DRUG AND DEVICE DEVELOPMENT
Not just an ophthalmology-focused CRO, Iris Pharma helps clients around the world navigate every stage of the drug and device development process and delivers customized solutions for:
- Assessing possible therapeutic effect in ocular diseases
- Adding value to promising drug candidates or medical devices
- Designing development plans and preclinical packages and carrying out studies to proceed with confidence from bench to bedside
- Providing the comprehensive clinical development services you need, from Phase I through Phase IV and Post-marketing follow-through
Iris Pharma’s a la carte services include:
- in vivo screening
- Proof of concept studies
- Efficacy studies in animal models of ophthalmic diseases (eg. AMD, DR, DED, glaucoma, uveitis)
- GLP preclinical studies
- Bioanalytical testing services
- Clinical trials and clinical research services
- Post marketing surveys
Our assets:
- 33 years of experience in the field of ophthalmology research
- All ophthalmic indications mastered
- 70 FDA, PMDA, EMA new ocular drug approvals and medical device marketing authorizations
- State-of-the-art medical and scientific equipment
- Highly specialized and qualified staff
Brands: Iris Pharma